Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups
- PMID: 11179016
- PMCID: PMC1274481
- DOI: 10.1086/318799
Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups
Abstract
Human narcolepsy-cataplexy, a sleep disorder associated with a centrally mediated hypocretin (orexin) deficiency, is tightly associated with HLA-DQB1*0602. Few studies have investigated the influence that additional HLA class II alleles have on susceptibility to this disease. In this work, 1,087 control subjects and 420 narcoleptic subjects with cataplexy, from three ethnic groups, were HLA typed, and the effects of HLA-DRB1, -DQA1, and -DQB1 were analyzed. As reported elsewhere, almost all narcoleptic subjects were positive for both HLA-DQA1*0102 and -DQB1*0602. A strong predisposing effect was observed in DQB1*0602 homozygotes, across all ethnic groups. Relative risks for narcolepsy were next calculated for heterozygous DQB1*0602/other HLA class II allelic combinations. Nine HLA class II alleles carried in trans with DQB1*0602 were found to influence disease predisposition. Significantly higher relative risks were observed for heterozygote combinations including DQB1*0301, DQA1*06, DRB1*04, DRB1*08, DRB1*11, and DRB1*12. Three alleles-DQB1*0601, DQB1*0501, and DQA1*01 (non-DQA1*0102)-were found to be protective. The genetic contribution of HLA-DQ to narcolepsy susceptibility was also estimated by use of lambda statistics. Results indicate that complex HLA-DR and -DQ interactions contribute to the genetic predisposition to human narcolepsy but that additional susceptibility loci are also most likely involved. Together with the recent hypocretin discoveries, these findings are consistent with an immunologically mediated destruction of hypocretin-containing cells in human narcolepsy-cataplexy.
References
Electronic-Database Information
-
- IMGT/HLA Sequence Database, http://www.ebi.ac.uk/imgt/hla/ (for HLA class II sequences)
-
- Online Mendelian Inheritance in Man (OMIN), http://www.ncbi.nlm.nih.gov/Omim/ (for narcolepsy [MIM 161400])
References
-
- Allcock RJ, de la Concha EG, Fernandez-Arquero M, Vigil P, Conejero L, Arroyo R, Price P (1999) Susceptibility to multiple sclerosis mediated by HLA-DRB1 is influenced by a second gene telomeric of the TNF cluster. Hum Immunol 60:1266–1273 - PubMed
-
- Carlander B, Eliaou JF, Billiard M (1993) Autoimmune hypothesis in narcolepsy. Neurophysiol Clin 23:15–22 - PubMed
-
- Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, Richardson JA, Williams SC, Xiong Y, Kisanuki Y, Fitch TE, Nakazato M, Hammer RE, Saper CB, Yanagisawa M (1999) Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98:437–451 - PubMed
-
- Ellis MC, Hetisimer AH, Ruddy DA, Hansen SL, Kronmal GS, McClelland E, Quintana L, Drayna DT, Aldrich MS, Mignot E (1997) HLA class II haplotype and sequence analysis support a role for DQ in narcolepsy. Immunogenetics 46:410–417 - PubMed
-
- Fernandez-Vina M, Gao X, Moraes ME, Moraes JR, Salatiel I, Miller S, Tsai J, Sun YP, An JB, Layrisse Z (1991) Alleles at four HLA class II loci determined by oligonucleotide hybridization and their associations in five ethnic groups. Immunogenetics 34:299–312 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
